Metropolitan Life Insurance Company (MetLife)’s Microvast MVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,774
Closed -$1.49K 1339
2024
Q1
$1.49K Sell
1,774
-11,303
-86% -$10.1K ﹤0.01% 2296
2023
Q4
$18.3K Buy
13,077
+6,918
+112% +$9.28K ﹤0.01% 1953
2023
Q3
$11.6K Hold
6,159
﹤0.01% 2148
2023
Q2
$9.85K Sell
6,159
-4,131
-40% -$5.89K ﹤0.01% 2308
2023
Q1
$12.8K Sell
10,290
-696
-6% -$1.01K ﹤0.01% 2075
2022
Q4
$16.8K Hold
10,986
﹤0.01% 2101
2022
Q3
$19.9K Hold
10,986
﹤0.01% 2032
2022
Q2
$24.4K Buy
+10,986
New +$47.2K ﹤0.01% 1944

Other funds holding MVST

Metropolitan Life Insurance Company (MetLife)'s MVST Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Microvast (MVST) in Q2 2024, closing a stake of 1,774 shares — an estimated $1.49K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MVST in Q2 2022 and held it in 8 quarters. The position peaked at $24.4K in Q2 2022. 90 funds tracked by Wall St. Rank hold MVST as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Microvast position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,774 Microvast shares in Q2 2024, an estimated $1.49K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Microvast in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Microvast position peaked at $24.4K in Q2 2022.
  • 90 funds tracked by Wall St. Rank held Microvast as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.